Literature DB >> 16641127

Relations among questionnaire and laboratory measures of rhinovirus infection.

B Barrett1, R Brown, R Voland, R Maberry, R Turner.   

Abstract

Due to high incidence and quality-of-life impact, upper respiratory infection substantially impacts on population health. To test or compare treatment effectiveness, a well-designed and validated illness-specific quality-of-life instrument is needed. Data reported in the current study were obtained from a trial testing echinacea for induced rhinovirus infection. Laboratory-assessed biomarkers included interleukin (IL)-8, nasal neutrophil count (polymorphonuclear neutrophils (PMN)), mucus weight, viral titre and seroconversion. The questionnaires used included the general health short form (SF)-8 (24-h recall version), the eight-item Jackson cold scale, and the 44-item Wisconsin Upper Respiratory Symptom Survey (WURSS). In total, 399 participants were inoculated with rhinovirus and monitored over 2,088 person-days. Statistically significant associations were found among nearly all variables. Between-questionnaire correlations were: WURSS-Jackson = 0.81; WURSS-SF-8 = 0.62; and Jackson-SF-8 = 0.60. Correlations with laboratory values were as follows: WURSS-mucus weight = 0.53; Jackson-mucus weight = 0.55; WURSS-viral titre = 0.37; Jackson-viral titre = 0.46; WURSS-IL-8 = 0.31; Jackson-IL-8 = 0.36; WURSS-PMN = 0.31; and Jackson-PMN = 0.28. Neither WURSS nor Jackson yielded satisfactory cut-off scores for diagnosis of infection. Symptomatic and biological outcomes of upper respiratory infection are highly variable, with only modest associations. While Wisconsin Upper Respiratory Symptom Survey and Jackson questionnaires both correlate with biomarkers, neither is a good predictor of induced infection. The inclusion of functional and quality-of-life items in the Wisconsin Upper Respiratory Symptom Survey does not significantly decrease the strength of association with laboratory-assessed biomarkers.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16641127     DOI: 10.1183/09031936.06.00002606

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  32 in total

1.  Meditation or exercise for preventing acute respiratory infection: a randomized controlled trial.

Authors:  Bruce Barrett; Mary S Hayney; Daniel Muller; David Rakel; Ann Ward; Chidi N Obasi; Roger Brown; Zhengjun Zhang; Aleksandra Zgierska; James Gern; Rebecca West; Tola Ewers; Shari Barlow; Michele Gassman; Christopher L Coe
Journal:  Ann Fam Med       Date:  2012 Jul-Aug       Impact factor: 5.166

2.  Effect of probiotic on innate inflammatory response and viral shedding in experimental rhinovirus infection - a randomised controlled trial.

Authors:  R B Turner; J A Woodfolk; L Borish; J W Steinke; J T Patrie; L M Muehling; S Lahtinen; M J Lehtinen
Journal:  Benef Microbes       Date:  2017-03-27       Impact factor: 4.205

3.  Placebo effects and the common cold: a randomized controlled trial.

Authors:  Bruce Barrett; Roger Brown; Dave Rakel; David Rabago; Lucille Marchand; Jo Scheder; Marlon Mundt; Gay Thomas; Shari Barlow
Journal:  Ann Fam Med       Date:  2011 Jul-Aug       Impact factor: 5.166

4.  Gene expression signatures diagnose influenza and other symptomatic respiratory viral infections in humans.

Authors:  Aimee K Zaas; Minhua Chen; Jay Varkey; Timothy Veldman; Alfred O Hero; Joseph Lucas; Yongsheng Huang; Ronald Turner; Anthony Gilbert; Robert Lambkin-Williams; N Christine Øien; Bradly Nicholson; Stephen Kingsmore; Lawrence Carin; Christopher W Woods; Geoffrey S Ginsburg
Journal:  Cell Host Microbe       Date:  2009-08-06       Impact factor: 21.023

5.  A host-based RT-PCR gene expression signature to identify acute respiratory viral infection.

Authors:  Aimee K Zaas; Thomas Burke; Minhua Chen; Micah McClain; Bradly Nicholson; Timothy Veldman; Ephraim L Tsalik; Vance Fowler; Emanuel P Rivers; Ronny Otero; Stephen F Kingsmore; Deepak Voora; Joseph Lucas; Alfred O Hero; Lawrence Carin; Christopher W Woods; Geoffrey S Ginsburg
Journal:  Sci Transl Med       Date:  2013-09-18       Impact factor: 17.956

6.  Validation of the Nasal Mucus Index, a novel measurement of acute respiratory infection severity.

Authors:  Paul M Dorresteijn; Daniel Muller; Yaoguo Xie; Zhengjun Zhang; Bruce P Barrett
Journal:  Am J Rhinol Allergy       Date:  2016-09       Impact factor: 2.467

7.  Comparison of anchor-based and distributional approaches in estimating important difference in common cold.

Authors:  Bruce Barrett; Roger Brown; Marlon Mundt
Journal:  Qual Life Res       Date:  2007-11-20       Impact factor: 4.147

8.  Practitioner empathy and the duration of the common cold.

Authors:  David P Rakel; Theresa J Hoeft; Bruce P Barrett; Betty A Chewning; Benjamin M Craig; Min Niu
Journal:  Fam Med       Date:  2009 Jul-Aug       Impact factor: 1.756

9.  Item reduction of the Wisconsin Upper Respiratory Symptom Survey (WURSS-21) leads to the WURSS-11.

Authors:  Chidi N Obasi; Roger L Brown; Bruce P Barrett
Journal:  Qual Life Res       Date:  2013-10-20       Impact factor: 4.147

10.  Validation of a short form Wisconsin Upper Respiratory Symptom Survey (WURSS-21).

Authors:  Bruce Barrett; Roger L Brown; Marlon P Mundt; Gay R Thomas; Shari K Barlow; Alex D Highstrom; Mozhdeh Bahrainian
Journal:  Health Qual Life Outcomes       Date:  2009-08-12       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.